Emerging Trends Influencing The Growth Of The Intranasal Drug Delivery Devices Market: Innovative Intranasal Drug Delivery Technology

"The Intranasal Drug Delivery Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Intranasal Drug Delivery Devices Market Size Expected to Be by 2034?
Over recent years, the intranasal drug delivery devices market has seen strong growth. An expansion from $60.27 billion in 2024 to $65.59 billion in 2025, with a compound annual growth rate (CAGR) of 8.8% is projected. This robust growth during the historical period can be related to increasing chronic respiratory illnesses, patient adherence and preference, ease of self-administration, pediatric use, market growth in treating allergic rhinitis, and broader indications.

In the coming years, the market size for intranasal drug delivery devices is slated to experience robust growth. Its worth is projected to reach $92.05 billion in 2029, with a compound annual growth rate (CAGR) of 8.8%. The growth projected for this period can be credited to factors such as the escalating aged population, the surge in respiratory diseases worldwide, widening use in neurologic disorders, the shift towards personalized medicine, proactive health care measures, and market expansion in developing economies. Key trends for this period will include technological advancements in formulation, an emphasis on pediatric and geriatric usage, an increase in self-administered devices, a rise in nasal powder inhalers, and the integration of biologics and peptides.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13463

What Are the Emerging Segments Within the Intranasal Drug Delivery Devices Market?
The intranasal drug delivery devices market covered in this report is segmented -

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:
1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device
2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device
3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs
4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

What Long-Term Drivers Are Shaping Intranasal Drug Delivery Devices Market Trends?
The rise in chronic diseases is projected to boost the intranasal drug delivery devices market's development. Chronic diseases are those that persist for a year or longer, necessitating continuous medical care, limiting everyday activities, or both. Intranasal drug delivery devices are used to manage these chronic conditions by providing an efficient, non-invasive method of delivering medication. These devices deliver medication directly to the affected area, making it convenient, easy to use, and promoting swift absorption. For instance, the National Health Service, a UK-based government department, indicated that in June 2024, it had identified an additional 549,000 individuals in England at risk of developing type 2 diabetes in 2023. Consequently, the number of people registered with a GP as having non-diabetic hyperglycemia or pre-diabetes jumped to 3,615,330 - a nearly 20% increase from 3,065,825 in 2022. As a result, the rising prevalence of chronic diseases is fueling the intranasal drug delivery devices market's growth. The rise in demand for non-invasive methods of drug delivery is expected to bolster the intranasal drug delivery devices market's progression. Non-invasive drug administration refers to injecting pharmaceutical substances into the body without penetrating or incising the skin or mucous membranes. Intranasal drug delivery devices, used in non-invasive drug delivery, are quick and effective for administering medicine through the nose. These devices leverage the nose's extensive blood vessel network and rapid absorption, improving the bioavailability of drugs and ensuring patient compliance while eliminating the need for invasive procedures. For instance, The Aesthetic Society, a US-based medical association, reported in August 2023 that non-surgical procedures in the U.S. such as body contouring, skin treatment, toxins, and micro needling had witnessed growth rates of 31%, 26%, 24%, and 23% respectively in 2022. Thus, the burgeoning demand for non-invasive drug delivery methods is driving the intranasal drug delivery devices market's growth.

Who Are the Top Competitors in Key Intranasal Drug Delivery Devices Market Segments?
Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Biotechnology Corporation

What Are the Major Trends Shaping the Intranasal Drug Delivery Devices Market?
Leading companies in the nasal drug delivery technology market are focusing on creating innovative products to offer novel drug administration solutions and maintain their market standing. As an example, in January 2023, the AptarGroup, Inc., a pharmaceutical and drug delivery firm in the US, introduced its first recyclable, multi-dose nasal spray that's devoid of metal, the APF Futurity. It's primarily intended for delivering nasal saline and similar over-the-counter medications. The APF Futurity, created using polyolefin materials, is devoid of any metal components or recycling disruptors, which eliminates the need for separation during recycling and contributes to an improved quality of recycled materials. What distinguishes this product is its recyclability design - a highly recyclable nasal spray pump that has been granted Class AA certification from cyclos-HTP, validating it for recycling in Europe.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

Which Regions Are Becoming Hubs for Intranasal Drug Delivery Devices Market Innovation?
North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Intranasal Drug Delivery Devices Market?
2. What is the CAGR expected in the Intranasal Drug Delivery Devices Market?
3. What Are the Key Innovations Transforming the Intranasal Drug Delivery Devices Industry?
4. Which Region Is Leading the Intranasal Drug Delivery Devices Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.